Literature DB >> 9566286

Amebic osteomyelitis in a child with acquired immunodeficiency syndrome: a case report.

D M Selby1, R S Chandra, T A Rakusan, B Loechelt, B M Markle, G S Visvesvara.   

Abstract

Disseminated Acanthamoeba infection has been described in immunocompromised or debilitated patients. The usual sites of involvement are skin, sinus, and brain. Sporadic reports of Acanthamoeba infection in patients infected with the human immunodeficiency virus are present in recent literature, predominantly in adults, and one case involving an 8-year-old child. We describe a case of amebic osteomyelitis, seen in a 6-year-old child with vertically acquired human immunodeficiency virus and a 6-month history of cutaneous Acanthamoeba infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566286

Source DB:  PubMed          Journal:  Pediatr Pathol Lab Med        ISSN: 1077-1042


  8 in total

Review 1.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii.

Authors:  A Mattana; G Biancu; L Alberti; A Accardo; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Granulomatous amebic encephalitis in a patient with AIDS: isolation of acanthamoeba sp. Group II from brain tissue and successful treatment with sulfadiazine and fluconazole.

Authors:  M Seijo Martinez; G Gonzalez-Mediero; P Santiago; A Rodriguez De Lope; J Diz; C Conde; G S Visvesvara
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 4.  Pathogenic free-living amoebae in Korea.

Authors:  Ho-Joon Shin; Kyung-il Im
Journal:  Korean J Parasitol       Date:  2004-09       Impact factor: 1.341

Review 5.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

6.  Amebic osteomyelitis in an immunocompromised patient.

Authors:  Matthew Breland; Nicholas Beckmann
Journal:  Radiol Case Rep       Date:  2016-06-23

7.  A Review of the Current Research Trends in the Application of Medicinal Plants as a Source for Novel Therapeutic Agents Against Acanthamoeba Infections.

Authors:  Maryam Niyyati; Samira Dodangeh; Jacob Lorenzo-Morales
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

Review 8.  Osteomyelitis in Immunocompromised children and neonates, a case series.

Authors:  Bryan Foong; Kenneth Pak Leung Wong; Carolin Joseph Jeyanthi; Jiahui Li; Kevin Boon Leong Lim; Natalie Woon Hui Tan
Journal:  BMC Pediatr       Date:  2021-12-11       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.